11.25
price down icon0.35%   -0.04
after-market After Hours: 11.70 0.45 +4.00%
loading
Meiragtx Holdings Plc stock is traded at $11.25, with a volume of 630.50K. It is down -0.35% in the last 24 hours and up +52.23% over the past month. MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
See More
Previous Close:
$11.29
Open:
$11.4
24h Volume:
630.50K
Relative Volume:
1.30
Market Cap:
$916.27M
Revenue:
$81.39M
Net Income/Loss:
$-114.20M
P/E Ratio:
-7.8931
EPS:
-1.4253
Net Cash Flow:
$-50.60M
1W Performance:
+19.81%
1M Performance:
+52.23%
6M Performance:
+38.21%
1Y Performance:
+106.42%
1-Day Range:
Value
$11.07
$11.85
1-Week Range:
Value
$8.875
$11.85
52-Week Range:
Value
$4.55
$11.85

Meiragtx Holdings Plc Stock (MGTX) Company Profile

Name
Name
Meiragtx Holdings Plc
Name
Phone
646-860-7985
Name
Address
655 THIRD AVENUE, NEW YORK, NY
Name
Employee
403
Name
Twitter
@MeiraGTx
Name
Next Earnings Date
2026-03-26
Name
Latest SEC Filings
Name
MGTX's Discussions on Twitter

Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
MGTX icon
MGTX
Meiragtx Holdings Plc
11.25 919.53M 81.39M -114.20M -50.60M -1.4253
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
441.70 113.01B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
753.93 79.87B 14.34B 4.50B 3.77B 41.56
ARGX icon
ARGX
Argen X Se Adr
840.87 51.51B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
333.39 45.29B 3.71B 313.75M 465.38M 2.2571
ONC icon
ONC
Beone Medicines Ltd Adr
319.94 34.41B 5.36B 287.73M 924.18M 2.5229

Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-24-25 Initiated H.C. Wainwright Buy
Oct-21-25 Initiated Raymond James Strong Buy
Jul-31-24 Resumed Chardan Capital Markets Buy
Oct-23-20 Initiated RBC Capital Mkts Outperform
Sep-15-20 Resumed BofA Securities Buy
Sep-03-19 Initiated Piper Jaffray Overweight
Feb-27-19 Reiterated Chardan Capital Markets Buy
Jul-03-18 Initiated Barclays Overweight
Jul-03-18 Initiated BofA/Merrill Buy
View All

Meiragtx Holdings Plc Stock (MGTX) Latest News

pulisher
02:26 AM

MeiraGTx rises on upcoming phase 1 readout for gene therapy - MSN

02:26 AM
pulisher
01:26 AM

MeiraGTx: Turning Dry Mouth Into Liquid Gold (NASDAQ:MGTX) - Seeking Alpha

01:26 AM
pulisher
12:30 PM

MeiraGTx Holdings (MGTX) Shares Surge 17% on Upcoming Gene Thera - GuruFocus

12:30 PM
pulisher
Apr 14, 2026

MeiraGTx to present 3-year data from xerostomia gene therapy trial - Investing.com India

Apr 14, 2026
pulisher
Apr 14, 2026

MeiraGTx sets trial readout for gene therapy (MGTX:NASDAQ) - Seeking Alpha

Apr 14, 2026
pulisher
Apr 14, 2026

MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 - Bitget

Apr 14, 2026
pulisher
Apr 13, 2026

Quarterly Recap: What is the earnings history of MeiraGTx Holdings plc2026 Setups & Growth Focused Investment Plans - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 11, 2026

Earnings Recap: How liquid is MeiraGTx Holdings plc stockTrade Exit Report & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 08, 2026

Naylor, MeiraGTx chief dev. officer, sells $258,906 in shares By Investing.com - Investing.com Canada

Apr 08, 2026
pulisher
Apr 07, 2026

Insider Sell Alert: Stuart Naylor Sells Shares of MeiraGTx Holdings PLC - GuruFocus

Apr 07, 2026
pulisher
Apr 07, 2026

MeiraGTx (MGTX) CDO Stuart Naylor sells 27,661 shares via 10b5-1 plan - Stock Titan

Apr 07, 2026
pulisher
Apr 07, 2026

Naylor, MeiraGTx chief dev. officer, sells $258,906 in shares - Investing.com

Apr 07, 2026
pulisher
Apr 07, 2026

[144] MeiraGTx Holdings plc SEC Filing - Stock Titan

Apr 07, 2026
pulisher
Apr 06, 2026

MeiraGTx (NASDAQ:MGTX) Hits New 52-Week HighTime to Buy? - MarketBeat

Apr 06, 2026
pulisher
Apr 05, 2026

MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat

Apr 05, 2026
pulisher
Apr 04, 2026

(MGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Apr 04, 2026
pulisher
Apr 04, 2026

MGTX Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026
pulisher
Apr 02, 2026

What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Sahm

Apr 02, 2026
pulisher
Apr 01, 2026

MeiraGTx Holdings plc Ordinary Shares MGTX ) Stock Price Today & Analysis - Gotrade

Apr 01, 2026
pulisher
Apr 01, 2026

MeiraGTx Holdings plc Ordinary Shares (MGTX) Stock Price Today & Analysis - heygotrade.com

Apr 01, 2026
pulisher
Apr 01, 2026

MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs | MGTX Stock News - GuruFocus

Apr 01, 2026
pulisher
Apr 01, 2026

MeiraGTx Holdings PLC $MGTX Shares Bought by Hennion & Walsh Asset Management Inc. - MarketBeat

Apr 01, 2026
pulisher
Apr 01, 2026

MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs - GuruFocus

Apr 01, 2026
pulisher
Mar 31, 2026

Strength Displayed by MeiraGTx (MGTX): Will Its 6.2% Surge Lead to Further Gains? - Bitget

Mar 31, 2026
pulisher
Mar 31, 2026

Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? - Yahoo Finance

Mar 31, 2026
pulisher
Mar 30, 2026

Performance Recap: Can MeiraGTx Holdings plc deliver consistent EPS growth2026 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 30, 2026

MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st

Mar 30, 2026
pulisher
Mar 30, 2026

MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance

Mar 30, 2026
pulisher
Mar 30, 2026

MeiraGTx 2025 Annual Report Highlights: Gene Therapy Pipeline, Strategic Partnerships, and Proprietary Riboswitch Platform - Minichart

Mar 30, 2026
pulisher
Mar 30, 2026

MeiraGTx 2025 10-K: Revenue $81.4M, EPS (1.42) - TradingView

Mar 30, 2026
pulisher
Mar 30, 2026

MeiraGTx (NASDAQ: MGTX) expands gene therapy partnerships and manufacturing - Stock Titan

Mar 30, 2026
pulisher
Mar 29, 2026

MeiraGTx Holdings plc (MGTX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union

Mar 29, 2026
pulisher
Mar 29, 2026

Live MeiraGTx Holdings plc (MGTX) Technical Analysis - tradersunion.com

Mar 29, 2026
pulisher
Mar 29, 2026

Bank of America Forecasts Strong Price Appreciation for MeiraGTx (NASDAQ:MGTX) Stock - Defense World

Mar 29, 2026
pulisher
Mar 29, 2026

MeiraGTx Holdings plc (MGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Mar 29, 2026
pulisher
Mar 28, 2026

MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 28, 2026
pulisher
Mar 28, 2026

MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN

Mar 28, 2026
pulisher
Mar 27, 2026

Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com Australia

Mar 27, 2026
pulisher
Mar 27, 2026

Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

Piper Sandler cuts MeiraGTx stock price target on valuation - Investing.com UK

Mar 27, 2026
pulisher
Mar 27, 2026

MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat

Mar 27, 2026
pulisher
Mar 27, 2026

MeiraGTx Receives FDA Breakthrough Therapy Designation for AAV2-hAQP1 and Reports Strong 2025 Financial Results - Minichart

Mar 27, 2026
pulisher
Mar 26, 2026

BofA raises MeiraGTx stock price target to $16 on FDA designation - uk.investing.com

Mar 26, 2026
pulisher
Mar 26, 2026

BofA raises MeiraGTx stock price target to $16 on FDA designation By Investing.com - Investing.com India

Mar 26, 2026
pulisher
Mar 26, 2026

MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks

Mar 26, 2026
pulisher
Mar 26, 2026

MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Mar 26, 2026
pulisher
Mar 26, 2026

MeiraGTx shares see Raymond James price target cut on launch timing By Investing.com - Investing.com South Africa

Mar 26, 2026

Meiragtx Holdings Plc Stock (MGTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Cap:     |  Volume (24h):